Original Research

DOI: 10.4244/EIJ-D-24-00037

Treatment extent of femoropopliteal disease and clinical outcomes following endovascular therapy

Yong-Hoon Yoon1, MD, PhD; Jae-Hwan Lee1, MD, PhD; Won-Mook Hwang1, MD; Hyun-Woong Park1, MD, PhD; Jae-Hyung Roh1, MD, PhD; Seung-Jun Lee2, MD, PhD; Young-Guk Ko2, MD, PhD; Chul-Min Ahn2, MD, PhD; Cheol Woong Yu3, MD, PhD; Seung-Whan Lee4, MD, PhD; Young Jin Youn5, MD, PhD; Jong Kwan Park6, MD, PhD; Chang-Hwan Yoon7,8, MD, PhD; Seung-Woon Rha9, MD, PhD; Pil-Ki Min10, MD, PhD; Seung-Hyuk Choi11, MD, PhD; In-Ho Chae7,8, MD, PhD; Donghoon Choi2, MD, PhD

Abstract

BACKGROUND: Endovascular therapy (EVT) has become the preferred treatment modality for femoropopliteal disease. However, there is limited evidence regarding its procedural and clinical outcomes according to the affected area.

AIMS: The aim of this study is to investigate clinical outcomes and device effectiveness according to treatment extent in the superficial femoral artery (SFA), popliteal artery (PA), or both.

METHODS: In this study, we analysed EVT for SFA (2,404 limbs), PA (155 limbs), SFA/PA (383 limbs) using the population in the K-VIS ELLA (Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases) registry. The primary endpoint was target lesion revascularisation (TLR) at 2 years.

RESULTS: The SFA/PA group exhibited a higher prevalence of anatomical complexity, characterised by long lesions, moderate to severe calcification, and total occlusion. The procedures were successful in 97.2% of SFA, 92.9% of PA, and 95.6% of SFA/PA EVTs. The 2-year TLR rates were 21.1%, 18.6%, and 32.7% in the SFA, PA, and SFA/PA groups, respectively. SFA/PA EVT was associated with a significantly increased risk for TLR compared to the SFA group (adjusted hazard...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 18
Sep 16, 2024
Volume 20 Number 18
View full issue


Key metrics

On the same subject
Trending articles
203.9

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
75.15

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
69.7

Clinical research

10.4244/EIJ-D-20-00763 Dec 18, 2020
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system
Verheye S et al
free
58.35

Clinical research

10.4244/EIJ-D-20-00975 May 16, 2021
Revascularisation or medical therapy in elderly patients with acute anginal syndromes: the RINCAL randomised trial
de Belder A et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved